Regeneration and repair of neural tissue using postpartum-derived cells

Details for Australian Patent Application No. 2004252568 (hide)

Owner Ethicon, Incorporated

Inventors Kihm, Anthony J.; Yi, Chin-Feng; Harmon, Alexander M.; Gosiewska, Anna; Messina, Darin J.; Seyda, Agnieszka; Harris, Ian Ross; Mistry, Sanjay

Agent Pizzeys

Pub. Number AU-B-2004252568

PCT Pub. Number WO2005/001078

Priority 60/483,264 27.06.03 US

Filing date 25 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 30 June 2011

International Classifications

C12N 5/073 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic cells or tissues

C12N 5/074 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Adult stem cells

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/001078 Priority application(s): WO2005/001078

30 June 2011 Application Accepted

  Published as AU-B-2004252568

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252570-Soft tissue repair and regeneration using postpartum-derived cells

2004252567-Repair and regeneration of ocular tissue using postpartum-derived cells